Home › NDC Lookup › RxCUI directory › RxCUI 434018

Doxycycline hyclate 100 MG Delayed Release Oral Tablet — RxCUI 434018

RxNorm drug concept · Semantic clinical drug
RxCUI 434018 Semantic clinical drug · SCD ● Current RxNorm concept 13 FDA products 40 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI434018
Official nameDoxycycline hyclate 100 MG Delayed Release Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped13
Package NDCs mapped40
Reported Medicaid activity (SDUD)1,275 prescriptions · 11 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Doxycycline Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • The IV form is used when you're not able to swallow or absorb oral medication — for example, if you're too sick, vomiting, or need a faster, more reliable delivery of the antibioti...
  • Why am I getting doxycycline through an IV instead of just taking a pill?
  • It depends on what infection you're being treated for. For most infections, treatment continues for at least 24 to 48 hours after your fever and symptoms have cleared. For somethin...
  • How long will I need to be on this antibiotic?
📖 Read our full Doxycycline Injection guide →

🕸️ Concept Web — How Doxycycline hyclate 100 MG Delayed Release Oral... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Doxycycline hyclate 100 MG Delayed Release Oral Tablet RxCUI 434018

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Doxycycline 3640
    • Doxycycline hyclate 23663
  2. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Doxycycline Delayed Release Oral Tablet 439221
    • Doxycycline hyclate Delayed Release Oral Tablet 2648584
    • Doxycycline Oral Product 1160778
    • Doxycycline Pill 1160779
    • Doxycycline hyclate Oral Product 2663263
    • Doxycycline hyclate Pill 2661949
    • Delayed Release Oral Tablet 10312
    • Oral Product 1151131
    • +1 more in this family
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Doxycycline hyclate 100 MG 1649987

Showing up to 8 concepts per family — 11 of 12 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Doxycycline hyclate 100 MG SCDC · 1649987
  • Doxycycline Delayed Release Oral Tablet SCDF · 439221
  • Doxycycline hyclate Delayed Release Oral Tablet SCDFP · 2648584
  • Doxycycline Oral Product SCDG · 1160778
  • Doxycycline Pill SCDG · 1160779
  • Doxycycline hyclate Oral Product SCDGP · 2663263
  • Doxycycline hyclate Pill SCDGP · 2661949

📦 FDA Products & Package NDCs

13 products · 40 package NDCs
40 package NDCs map to RxCUI 434018 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
23155-0141-01 100 TABLET, DELAYED RELEASE in 1 BOTTLE (23155-141-01) DOXYCYCLINE HYCLATE DELAYED RELEASE Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. 2013-04-30
23155-0141-05 500 TABLET, DELAYED RELEASE in 1 BOTTLE (23155-141-05) DOXYCYCLINE HYCLATE DELAYED RELEASE Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. 2013-04-30
23155-0141-06 60 TABLET, DELAYED RELEASE in 1 BOTTLE (23155-141-06) DOXYCYCLINE HYCLATE DELAYED RELEASE Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. 2013-04-30
23155-0142-01 100 TABLET, DELAYED RELEASE in 1 BOTTLE (23155-142-01) DOXYCYCLINE HYCLATE DELAYED RELEASE Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. 2013-04-30
23155-0142-05 500 TABLET, DELAYED RELEASE in 1 BOTTLE (23155-142-05) DOXYCYCLINE HYCLATE DELAYED RELEASE Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. 2013-04-30
23155-0143-01 100 TABLET, DELAYED RELEASE in 1 BOTTLE (23155-143-01) DOXYCYCLINE HYCLATE DELAYED RELEASE Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. 2013-04-30
23155-0143-04 250 TABLET, DELAYED RELEASE in 1 BOTTLE (23155-143-04) DOXYCYCLINE HYCLATE DELAYED RELEASE Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. 2013-04-30
23155-0143-06 60 TABLET, DELAYED RELEASE in 1 BOTTLE (23155-143-06) DOXYCYCLINE HYCLATE DELAYED RELEASE Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. 2013-04-30
23155-0611-04 250 TABLET, DELAYED RELEASE in 1 BOTTLE (23155-611-04) DOXYCYCLINE HYCLATE DELAYED RELEASE Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. 2018-03-16
23155-0611-06 60 TABLET, DELAYED RELEASE in 1 BOTTLE (23155-611-06) DOXYCYCLINE HYCLATE DELAYED RELEASE Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. 2018-03-16
46708-0481-31 100 TABLET, DELAYED RELEASE in 1 BOTTLE (46708-481-31) Doxycycline Hyclate Alembic Pharmaceuticals Limited 2022-01-04
46708-0481-60 60 TABLET, DELAYED RELEASE in 1 BOTTLE (46708-481-60) Doxycycline Hyclate Alembic Pharmaceuticals Limited 2022-01-04
46708-0481-91 1000 TABLET, DELAYED RELEASE in 1 BOTTLE (46708-481-91) Doxycycline Hyclate Alembic Pharmaceuticals Limited 2022-01-04
46708-0482-31 100 TABLET, DELAYED RELEASE in 1 BOTTLE (46708-482-31) Doxycycline Hyclate Alembic Pharmaceuticals Limited 2022-01-04
46708-0482-60 60 TABLET, DELAYED RELEASE in 1 BOTTLE (46708-482-60) Doxycycline Hyclate Alembic Pharmaceuticals Limited 2022-01-04
46708-0482-91 1000 TABLET, DELAYED RELEASE in 1 BOTTLE (46708-482-91) Doxycycline Hyclate Alembic Pharmaceuticals Limited 2022-01-04
46708-0483-30 30 TABLET, DELAYED RELEASE in 1 BOTTLE (46708-483-30) Doxycycline Hyclate Alembic Pharmaceuticals Limited 2023-03-07
46708-0483-31 100 TABLET, DELAYED RELEASE in 1 BOTTLE (46708-483-31) Doxycycline Hyclate Alembic Pharmaceuticals Limited 2022-01-04
46708-0483-60 60 TABLET, DELAYED RELEASE in 1 BOTTLE (46708-483-60) Doxycycline Hyclate Alembic Pharmaceuticals Limited 2022-01-04
46708-0483-71 500 TABLET, DELAYED RELEASE in 1 BOTTLE (46708-483-71) Doxycycline Hyclate Alembic Pharmaceuticals Limited 2022-01-04
46708-0484-30 30 TABLET, DELAYED RELEASE in 1 BOTTLE (46708-484-30) Doxycycline Hyclate Alembic Pharmaceuticals Limited 2022-10-15
46708-0484-31 100 TABLET, DELAYED RELEASE in 1 BOTTLE (46708-484-31) Doxycycline Hyclate Alembic Pharmaceuticals Limited 2022-01-04
46708-0484-60 60 TABLET, DELAYED RELEASE in 1 BOTTLE (46708-484-60) Doxycycline Hyclate Alembic Pharmaceuticals Limited 2022-01-04
46708-0484-71 500 TABLET, DELAYED RELEASE in 1 BOTTLE (46708-484-71) Doxycycline Hyclate Alembic Pharmaceuticals Limited 2022-01-04
62332-0481-31 100 TABLET, DELAYED RELEASE in 1 BOTTLE (62332-481-31) Doxycycline Hyclate Alembic Pharmaceuticals Inc. 2022-01-04
62332-0481-60 60 TABLET, DELAYED RELEASE in 1 BOTTLE (62332-481-60) Doxycycline Hyclate Alembic Pharmaceuticals Inc. 2022-01-04
62332-0481-91 1000 TABLET, DELAYED RELEASE in 1 BOTTLE (62332-481-91) Doxycycline Hyclate Alembic Pharmaceuticals Inc. 2022-01-04
62332-0482-31 100 TABLET, DELAYED RELEASE in 1 BOTTLE (62332-482-31) Doxycycline Hyclate Alembic Pharmaceuticals Inc. 2022-01-04
62332-0482-60 60 TABLET, DELAYED RELEASE in 1 BOTTLE (62332-482-60) Doxycycline Hyclate Alembic Pharmaceuticals Inc. 2022-01-04
62332-0482-91 1000 TABLET, DELAYED RELEASE in 1 BOTTLE (62332-482-91) Doxycycline Hyclate Alembic Pharmaceuticals Inc. 2022-01-04
62332-0483-30 30 TABLET, DELAYED RELEASE in 1 BOTTLE (62332-483-30) Doxycycline Hyclate Alembic Pharmaceuticals Inc. 2023-03-07
62332-0483-31 100 TABLET, DELAYED RELEASE in 1 BOTTLE (62332-483-31) Doxycycline Hyclate Alembic Pharmaceuticals Inc. 2022-01-04
62332-0483-60 60 TABLET, DELAYED RELEASE in 1 BOTTLE (62332-483-60) Doxycycline Hyclate Alembic Pharmaceuticals Inc. 2022-01-04
62332-0483-71 500 TABLET, DELAYED RELEASE in 1 BOTTLE (62332-483-71) Doxycycline Hyclate Alembic Pharmaceuticals Inc. 2022-01-04
62332-0484-30 30 TABLET, DELAYED RELEASE in 1 BOTTLE (62332-484-30) Doxycycline Hyclate Alembic Pharmaceuticals Inc. 2022-10-15
62332-0484-31 100 TABLET, DELAYED RELEASE in 1 BOTTLE (62332-484-31) Doxycycline Hyclate Alembic Pharmaceuticals Inc. 2022-01-04
62332-0484-60 60 TABLET, DELAYED RELEASE in 1 BOTTLE (62332-484-60) Doxycycline Hyclate Alembic Pharmaceuticals Inc. 2022-01-04
62332-0484-71 500 TABLET, DELAYED RELEASE in 1 BOTTLE (62332-484-71) Doxycycline Hyclate Alembic Pharmaceuticals Inc. 2022-01-04
68308-0716-30 30 TABLET, DELAYED RELEASE in 1 BOTTLE (68308-716-30) Doxycycline Hyclate Mayne Pharma Commercial LLC 2017-12-18
68308-0716-60 60 TABLET, DELAYED RELEASE in 1 BOTTLE (68308-716-60) Doxycycline Hyclate Mayne Pharma Commercial LLC 2016-02-01
Observed labelers: Alembic Pharmaceuticals Inc. (14) · Alembic Pharmaceuticals Limited (14) · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. (10) · Mayne Pharma Commercial LLC (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.